DLH wins contract for CDC data management NCHHSTP DHP

0

ATLANTA, Aug. 18, 2021 (GLOBE NEWSWIRE) – DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of research, services and innovative healthcare solutions to federal agencies, today announced that it has been awarded a contract from the Center for Disease Control and Prevention (“CDC”) Data Management Services Division for data management and analysis, health informatics and research support. The contract includes a one-year base period, with four one-year options, for a total value of $ 35 million.

“We are delighted to partner with DHP to support their vision of an ‘HIV-free future’,” said Jeanine Christian, chair of DLH’s public health and scientific research business unit. “This contract extends DLH’s legacy in HIV research around the world. We are proud to bring our research and data science capacity to the important work the CDC does to assess opportunities to reduce the number of new HIV infections occurring each year, to increase the proportion of people infected with HIV. who know they are infected, and increase the number of people infected with HIV who are linked to appropriate prevention, care and services.

This contract complements DLH’s work in the public health and life sciences market. The project involves collaboration with epidemiologists, physicians, statisticians, computer scientists, data managers and analysts, and public health advisers across the United States. DLH will provide public health data management services for qualitative and quantitative scientific and non-scientific data, including research, surveillance, program monitoring, evaluation, statistical analysis and reporting support.

“DLH is delighted to strengthen its long-standing relationship with CDC and DHP through this important disease prevention work,” added Zach Parker, President and CEO of DLH. “It builds on many of the capabilities we have developed over the past few years and expands our footprint in our country’s fight against the spread of infectious disease. “

About DLH

DLH provides enhanced health and preparedness solutions for federal programs through research, development and innovative care processes. The company’s experts in public health, performance assessment and healthcare operations solve complex problems facing civilian and military customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, etc. With more than 2,200 employees dedicated to the idea that “Your Mission is Our Passion”, DLH brings a unique combination of experience in the government sector, a proven methodology and an unwavering commitment to public health to improve the lives of millions of people. For more information, visit www.DLHcorp.com.

Safe Harbor Declaration under the Private Securities Litigation Reform Act 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or the future financial performance of DLH. Any statement that refers to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including, without limitation, statements that the Company or its management “believe “,” Expects “,” anticipates “,” plans “,” intentions “and similar expressions) should be considered as forward-looking statements that involve risks and uncertainties that could cause actual events or actual results of DLH differ materially from those indicated by forward-looking statements. The forward-looking statements contained in this press release include, among other things, statements concerning estimates of future income. These statements reflect our belief and assumptions about future events which may not prove to be correct. Our actual results may differ materially from these forward-looking statements made in this press release due to various factors, including: the outbreak of the novel coronavirus (“COVID-19”), including measures to reduce its spread, and its impact on the economy and demand for our services are uncertain, cannot be predicted and may precipitate or exacerbate other risks and uncertainties; the risk that we may not realize the expected benefits of our recent or future acquisition; the challenges of managing larger and more extensive operations resulting from the acquisition; awarding of contracts in connection with invitations to tender for ongoing business and / or competitions for new business; compliance with new banking financial clauses and other covenants; changes in client budget priorities; public procurement (such as contestation of bids, setting aside small businesses, loss of work due to organizational conflicts of interest, etc.) and risks of termination; the ability to successfully integrate the operations of our recent acquisition and any future acquisitions; and other risks described in our documents with the SEC. For a discussion of these risks and uncertainties that could cause actual results to differ from those contained in forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our annual report. on Form 10-K for the fiscal year ended September 30, 2020, as well as subsequent reports filed thereafter. The forward-looking statements contained in this document are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and our business. These forward-looking statements are made as of the date hereof and may become obsolete over time. The Company assumes no responsibility for updating forward-looking statements, except as required by law.

CONTACTS:

RELATIONS WITH INVESTORS
Contact: Chris Witty
Telephone: 646-438-9385
Email: cwitty@darrowir.com


Source link

Share.

Leave A Reply